Results of a Markov Model Analysis to Assess the Cost-Effectiveness of a Single Tablet of Fixed-Dose Amlodipine and Atorvastatin for the Primary Prevention of Cardiovascular Disease in Korea

Grants

Funding Acknowledgements

Financial support for this study was provided by Pfizer Pharmaceuticals Korea Limited (Seoul, Korea) Pfizer was given the opportunity to review and comment on the manuscript before its submission for publication, but the study design; collection, analysis and interpretation of data; writing of the manuscript; and the decision to submit the manuscript for publication were undertaken independently by the authors.